See the Diabetes Destroyed Video – Click Here Pharmaceutical giants Merck have agreed to pay $8.4 billion for Cubist Pharmaceuticals in a major deal that sees the giant drug company move more deeply into the antibiotic area, including its focus upon diseases like diabetes. The move has been a response to more interest in some […]
